Congo Ebola Outbreak May Exceed 600 Cases as CEPI Warns No Bundibugyo Vaccine Exists
Updated
Updated · Reuters · May 21
Congo Ebola Outbreak May Exceed 600 Cases as CEPI Warns No Bundibugyo Vaccine Exists
10 articles · Updated · Reuters · May 21
CEPI chair Jane Halton said the Democratic Republic of Congo's Ebola outbreak is likely far larger than reported, with the identified caseload only the "top of the iceberg."
The outbreak in eastern Congo has 600 suspected cases and more than 130 suspected deaths, and Halton said the real toll is already in the many hundreds of cases and deaths.
Bundibugyo Ebola has no approved vaccine or virus-specific treatment, making CEPI's goal of producing a safe, effective shot within 100 days a "big lift."
CEPI said antibody collection had started before the outbreak and early-stage candidates are being pushed through preclinical safety work, with a trial in the current outbreak possible if communities give informed consent.
The World Health Organization has declared the outbreak a public health emergency of international concern, underscoring the global risk from a rarer Ebola strain.
With no vaccine for this Ebola strain, is the world losing a race against a known but neglected pathogen?
Officials warn Ebola cases are the 'tip of the iceberg.' How large is the true scale of this hidden epidemic?
Can traditional health measures stop a major Ebola outbreak in a conflict zone without a modern vaccine?
Bundibugyo Ebola Outbreak in Ituri, DRC (2026): Escalating Humanitarian Crisis and the Race for Medical Solutions
Overview
The Bundibugyo Ebola outbreak is a major public health crisis because there are no approved vaccines or treatments for this strain. This lack of medical countermeasures makes it much harder to contain the virus and care for patients, leaving healthcare workers with only supportive care options. As a result, the immediate impact on affected communities is severe, and controlling the spread of the virus is more difficult. The situation highlights the urgent need for accelerated research and clinical trials to develop effective solutions, as the current tools are not enough to stop the outbreak.